Sedana Medical (SEDANA) Stock Overview
A medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
SEDANA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Sedana Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 8.82 |
| 52 Week High | SEK 18.32 |
| 52 Week Low | SEK 7.90 |
| Beta | 0.78 |
| 1 Month Change | 4.88% |
| 3 Month Change | -8.60% |
| 1 Year Change | -28.87% |
| 3 Year Change | -60.80% |
| 5 Year Change | -88.93% |
| Change since IPO | 48.24% |
Recent News & Updates
SEDANA: Early Access Milestone And 2026 NDA Filing Will Support Upside
Analysts have kept their SEK fair value estimate for Sedana Medical unchanged at SEK 18.0. They cite only small tweaks to the discount rate, long term revenue growth, profit margin, and future P/E assumptions. What’s in the News for Sedana Medical No recent Sedana Medical specific news items were identified in the provided primary news sources.SEDANA: Early Access Milestone And 2026 NDA Filing Will Support Upside
Analysts kept their SEK 18.0 price target for Sedana Medical broadly unchanged, reflecting only very small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions in their models. What's in the News Sedana Medical reported that the first patient has been treated in its U.S. Early Access Program for inhaled sedation at Vanderbilt University Medical Center in Nashville, Tennessee.SEDANA: Early Access Program And NDA Timeline Will Drive Future Upside
Analysts have kept their SEK 18.0 price target for Sedana Medical broadly unchanged, with only modest tweaks to the discount rate, long term growth, margin assumptions, and a higher future P/E input explaining the refined valuation work. What's in the News Sedana Medical reported that the first patient has been treated in its U.S. Early Access Program for inhaled sedation, following U.S. Food and Drug Administration (FDA) approval of the program in April 2025 (Key Developments).Earnings Release: Here's Why Analysts Cut Their Sedana Medical AB (publ) (STO:SEDANA) Price Target To kr18.00
The quarterly results for Sedana Medical AB (publ) ( STO:SEDANA ) were released last week, making it a good time to...Recent updates
SEDANA: Early Access Milestone And 2026 NDA Filing Will Support Upside
Analysts have kept their SEK fair value estimate for Sedana Medical unchanged at SEK 18.0. They cite only small tweaks to the discount rate, long term revenue growth, profit margin, and future P/E assumptions. What’s in the News for Sedana Medical No recent Sedana Medical specific news items were identified in the provided primary news sources.SEDANA: Early Access Milestone And 2026 NDA Filing Will Support Upside
Analysts kept their SEK 18.0 price target for Sedana Medical broadly unchanged, reflecting only very small tweaks to discount rate, revenue growth, profit margin and future P/E assumptions in their models. What's in the News Sedana Medical reported that the first patient has been treated in its U.S. Early Access Program for inhaled sedation at Vanderbilt University Medical Center in Nashville, Tennessee.SEDANA: Early Access Program And NDA Timeline Will Drive Future Upside
Analysts have kept their SEK 18.0 price target for Sedana Medical broadly unchanged, with only modest tweaks to the discount rate, long term growth, margin assumptions, and a higher future P/E input explaining the refined valuation work. What's in the News Sedana Medical reported that the first patient has been treated in its U.S. Early Access Program for inhaled sedation, following U.S. Food and Drug Administration (FDA) approval of the program in April 2025 (Key Developments).Earnings Release: Here's Why Analysts Cut Their Sedana Medical AB (publ) (STO:SEDANA) Price Target To kr18.00
The quarterly results for Sedana Medical AB (publ) ( STO:SEDANA ) were released last week, making it a good time to...SEDANA: Early Access Program Progress Will Support Future Upside Potential
Analysts have reiterated their Sedana Medical price target at SEK18.0, with minor adjustments to assumptions around the discount rate, revenue growth, profit margin, and future P/E leading to the unchanged headline figure. What’s in the News The first patient in Sedana Medical’s U.S. Early Access Program has been treated at Vanderbilt University Medical Center, giving clinicians access to the company’s inhaled sedation treatment ahead of potential market authorization (company announcement).SEDANA: Early Access Milestone In U.S. Sedation Program Will Drive Upside
The analyst price target for Sedana Medical has been revised from SEK 21 to SEK 18. Analysts attribute this change to updated assumptions regarding fair value, discount rate, revenue growth, profit margins, and future P/E.Sedana Medical AB (publ) (STO:SEDANA) Just Reported, And Analysts Assigned A kr19.00 Price Target
Investors in Sedana Medical AB (publ) ( STO:SEDANA ) had a good week, as its shares rose 2.4% to close at kr10.18...What You Can Learn From Sedana Medical AB (publ)'s (STO:SEDANA) P/S After Its 26% Share Price Crash
To the annoyance of some shareholders, Sedana Medical AB (publ) ( STO:SEDANA ) shares are down a considerable 26% in...Sedana Medical AB (publ) (STO:SEDANA) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
It's been a mediocre week for Sedana Medical AB (publ) ( STO:SEDANA ) shareholders, with the stock dropping 13% to...Sedana Medical AB (publ) (STO:SEDANA) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Sedana Medical AB (publ) ( STO:SEDANA ) investors will be delighted, with the company turning in some strong numbers...There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 27% Price Jump
Sedana Medical AB (publ) ( STO:SEDANA ) shares have continued their recent momentum with a 27% gain in the last month...Analysts Have Made A Financial Statement On Sedana Medical AB (publ)'s (STO:SEDANA) First-Quarter Report
The investors in Sedana Medical AB (publ) 's ( STO:SEDANA ) will be rubbing their hands together with glee today, after...Sedana Medical AB (publ)'s (STO:SEDANA) Shares Climb 35% But Its Business Is Yet to Catch Up
Those holding Sedana Medical AB (publ) ( STO:SEDANA ) shares would be relieved that the share price has rebounded 35...
US Trials And Supplier Acquisition Will Open Global Markets
Successful U.S. trial results and pediatric approvals across multiple countries could significantly boost revenue and market protection, expanding sales demographics.Risks Still Elevated At These Prices As Sedana Medical AB (publ) (STO:SEDANA) Shares Dive 40%
Sedana Medical AB (publ) ( STO:SEDANA ) shareholders that were waiting for something to happen have been dealt a blow...Earnings Update: Sedana Medical AB (publ) (STO:SEDANA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Sedana Medical AB (publ) ( STO:SEDANA ) shareholders are probably feeling a little disappointed, since its shares fell...There's Reason For Concern Over Sedana Medical AB (publ)'s (STO:SEDANA) Massive 26% Price Jump
Sedana Medical AB (publ) ( STO:SEDANA ) shareholders are no doubt pleased to see that the share price has bounced 26...kr34.00: That's What Analysts Think Sedana Medical AB (publ) (STO:SEDANA) Is Worth After Its Latest Results
As you might know, Sedana Medical AB (publ) ( STO:SEDANA ) last week released its latest quarterly, and things did not...Sedana Medical AB (publ)'s (STO:SEDANA) 36% Cheaper Price Remains In Tune With Revenues
Sedana Medical AB (publ) ( STO:SEDANA ) shareholders that were waiting for something to happen have been dealt a blow...After Leaping 27% Sedana Medical AB (publ) (STO:SEDANA) Shares Are Not Flying Under The Radar
Sedana Medical AB (publ) ( STO:SEDANA ) shares have continued their recent momentum with a 27% gain in the last month...Sedana Medical AB (publ) Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Shareholders will be ecstatic, with their stake up 44% over the past week following Sedana Medical AB (publ) 's...Here's Why We're Not Too Worried About Sedana Medical's (STO:SEDANA) Cash Burn Situation
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...Optimistic Investors Push Sedana Medical AB (publ) (STO:SEDANA) Shares Up 34% But Growth Is Lacking
Sedana Medical AB (publ) ( STO:SEDANA ) shares have had a really impressive month, gaining 34% after a shaky period...Shareholder Returns
| SEDANA | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -1.6% | -1.5% | -0.8% |
| 1Y | -28.9% | -9.6% | 10.4% |
Return vs Industry: SEDANA underperformed the Swedish Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: SEDANA underperformed the Swedish Market which returned 10.4% over the past year.
Price Volatility
| SEDANA volatility | |
|---|---|
| SEDANA Average Weekly Movement | 6.7% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.5% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: SEDANA has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: SEDANA's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 116 | Johannes Doll | sedanamedical.com |
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Spain, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a syringe with a connection to fit the connector on the agent line of the Sedaconda ACD and Sedana Medical filling adapters; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for maintenance of sedation in intubated or tracheostomised mechanically ventilated adult and paediatric patients from 3 years of age; Sedaconda Filling Adapter, a single-use medical device; FlurAbsorb Pro-L and Pro-S; FlurAbsorb and Mounts; Scavenging Tube, a one piece pre-connected tube, that is designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; and Mindray exhaust connector enables to connect the exhaust of the ventilator to an active or passive scavenging system. The company was founded in 1999 and is headquartered in Danderyd, Sweden.
Sedana Medical AB (publ) Fundamentals Summary
| SEDANA fundamental statistics | |
|---|---|
| Market cap | SEK 868.21m |
| Earnings (TTM) | -SEK 39.52m |
| Revenue (TTM) | SEK 196.15m |
Is SEDANA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SEDANA income statement (TTM) | |
|---|---|
| Revenue | SEK 196.15m |
| Cost of Revenue | SEK 56.33m |
| Gross Profit | SEK 139.83m |
| Other Expenses | SEK 179.35m |
| Earnings | -SEK 39.52m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Jul 17, 2026
| Earnings per share (EPS) | -0.40 |
| Gross Margin | 71.28% |
| Net Profit Margin | -20.15% |
| Debt/Equity Ratio | 0% |
How did SEDANA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/15 19:04 |
| End of Day Share Price | 2026/07/15 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sedana Medical AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Östling | Pareto Securities |
| Filip Wiberg | Pareto Securities |